Publication:
Addendum to Letter to the Editor: Safety, efficacy, and authorization of eliglustat as a first-line therapy in Gaucher disease type 1

Loading...
Thumbnail Image

Date

2019

Authors

Journal Title

Journal ISSN

Volume Title

Publisher

Research Projects

Organizational Units

Journal Issue

Abstract

[No abstract available]

Description

Keywords

Citation

URI

https://doi.org/10.1016/j.bcmd.2019.04.003
 https://www.scopus.com/inward/record.uri?eid=2-s2.0-85064623158&doi=10.1016%2fj.bcmd.2019.04.003&partnerID=40&md5=d0b81b6e8d409ced6269304ca77f241d
 https://remedy.med.bg.ac.rs/handle/123456789/5489

Collections

Publikacije / Publications